Studies have detected the decreased expression level of LIFR and identified the tumor suppressor role of LIFR in different tumor types, such as liver cancer, breast cancer, gallbladder cancer, gastric cancer, lung cancer, pancreatic cancer, clear cell renal cell carcinoma, and colorectal cancer. This evidence concerns the gene LIFR and familial pancreatic carcinoma.